Holt C M, Francis S E, Gadsdon P A, Violaris A, Izzat M B, Angelini G D
Department of Cardiac Surgery, Northern General Hospital, Sheffield, United Kingdom.
Cardiovasc Res. 1994 Aug;28(8):1170-5. doi: 10.1093/cvr/28.8.1170.
The aim was to test the hypothesis that platelet derived growth factor (PDGF) is synthesized in intact coronary arteries and that it is associated with cell proliferation in atherosclerotic plaques.
Segments of human coronary artery obtained from heart transplant recipients were cultured in serum-free media for 24 h. Tissue viability was assessed by ATP concentration. Cell proliferation was determined by incorporation of [3H] thymidine, autoradiography, and proliferating cell nuclear antigen (PCNA) immunostaining. Coronary artery conditioned media were tested for mitogenic activity using a fibroblast proliferation bioassay. Reverse transcription polymerase chain reaction (RT-PCR) for PDGF A and B was subsequently performed in order to confirm the endogenous nature and isoform of this mitogen.
Tissue viability remained unchanged during culture, and cell proliferation was detected by incorporation of [3H] thymidine. Autoradiography and PCNA immunostaining showed proliferating cells within the intimal and medial layers. Coronary artery conditioned media produced significant stimulation of cell growth [127(SEM 29)%, n = 15] above that caused by culture medium alone. This mitogenic activity was inhibited by 42(8)% (n = 8) with a polyclonal neutralising antibody to PDGF. The endogenous nature of this mitogenic activity was confirmed by detection of PDGF-A and PDGF-B mRNA expression using RT-PCR and the identity of the amplified products confirmed by DNA sequencing.
The data provide evidence for active PDGF production and gene expression within cells of the vessel wall. They also suggest that endogenously produced PDGF may play a role in controlling vascular smooth muscle cell proliferation in human coronary arteries.
旨在验证血小板衍生生长因子(PDGF)在完整冠状动脉中合成且与动脉粥样硬化斑块中的细胞增殖相关这一假说。
取自心脏移植受者的人冠状动脉节段在无血清培养基中培养24小时。通过ATP浓度评估组织活力。通过[3H]胸苷掺入、放射自显影和增殖细胞核抗原(PCNA)免疫染色来测定细胞增殖。使用成纤维细胞增殖生物测定法检测冠状动脉条件培养基的促有丝分裂活性。随后进行PDGF A和B的逆转录聚合酶链反应(RT-PCR),以确认这种促有丝分裂原的内源性本质和亚型。
培养过程中组织活力保持不变,通过[3H]胸苷掺入检测到细胞增殖。放射自显影和PCNA免疫染色显示在内膜和中膜层中有增殖细胞。冠状动脉条件培养基对细胞生长产生了显著刺激[127(标准误29)%,n = 15],高于单独培养基所引起的刺激。用抗PDGF多克隆中和抗体可使这种促有丝分裂活性受到42(8)%的抑制(n = 8)。通过RT-PCR检测PDGF-A和PDGF-B mRNA表达证实了这种促有丝分裂活性的内源性本质,DNA测序证实了扩增产物的一致性。
数据为血管壁细胞内活跃产生PDGF和基因表达提供了证据。它们还表明内源性产生的PDGF可能在控制人冠状动脉血管平滑肌细胞增殖中起作用。